Discovery, characterization and biological evaluation of a novel (R)-4,4-difluoropiperidine scaffold as dopamine receptor 4 (D4R) antagonists

Daniel E. Jeffries, Jonathan O. Witt, Andrea L. McCollum, Kayla J. Temple, Miguel A. Hurtado, Joel M. Harp, Anna L. Blobaum, Craig W. Lindsley, Corey R. Hopkins

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Herein, we report the synthesis and structure–activity relationship of a novel series of (R)-4,4-difluoropiperidine core scaffold as dopamine receptor 4 (D4) antagonists. A series of compounds from this scaffold are highly potent against the D4receptor and selective against the other dopamine receptors. In addition, we were able to confirm the active isomer as the (R)-enantiomer via an X-ray crystal structure.

Original languageEnglish (US)
Pages (from-to)5757-5764
Number of pages8
JournalBioorganic and Medicinal Chemistry Letters
Volume26
Issue number23
DOIs
StatePublished - 2016

Keywords

  • Addiction
  • Difluoropiperidine
  • Dopamine 4 receptor
  • PD-LIDs
  • Selectivity

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Discovery, characterization and biological evaluation of a novel (R)-4,4-difluoropiperidine scaffold as dopamine receptor 4 (D<sub>4</sub>R) antagonists'. Together they form a unique fingerprint.

  • Cite this